IL133478A0 - Proliposome powders for inhalation stabilised by tocopherol - Google Patents

Proliposome powders for inhalation stabilised by tocopherol

Info

Publication number
IL133478A0
IL133478A0 IL13347898A IL13347898A IL133478A0 IL 133478 A0 IL133478 A0 IL 133478A0 IL 13347898 A IL13347898 A IL 13347898A IL 13347898 A IL13347898 A IL 13347898A IL 133478 A0 IL133478 A0 IL 133478A0
Authority
IL
Israel
Prior art keywords
stabilised
tocopherol
inhalation
proliposome powders
proliposome
Prior art date
Application number
IL13347898A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL133478A0 publication Critical patent/IL133478A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13347898A 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol IL133478A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (fr) 1997-06-27 1998-06-08 Poudres de proliposomes stabilisees par tocopherol et destinees a l'inhalation

Publications (1)

Publication Number Publication Date
IL133478A0 true IL133478A0 (en) 2001-04-30

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13347898A IL133478A0 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Country Status (18)

Country Link
EP (1) EP1001749A1 (fr)
JP (1) JP2002510311A (fr)
KR (1) KR20010014163A (fr)
CN (1) CN1260713A (fr)
AU (1) AU729100B2 (fr)
BR (1) BR9810280A (fr)
CA (1) CA2295028A1 (fr)
EE (1) EE9900601A (fr)
HU (1) HUP0003207A3 (fr)
ID (1) ID23192A (fr)
IL (1) IL133478A0 (fr)
IS (1) IS5304A (fr)
NO (1) NO996439L (fr)
NZ (1) NZ501672A (fr)
PL (1) PL337723A1 (fr)
SK (1) SK184899A3 (fr)
TR (1) TR199903271T2 (fr)
WO (1) WO1999000111A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
MX2007015577A (es) * 2005-06-09 2008-02-25 Biolipox Ab Metodo y composiciones para el tratamiento de trastornos inflamatorios.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2014180827A1 (fr) * 2013-05-06 2014-11-13 Dsm Ip Assets B. V. Formulation en poudre de vitamine e
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081474A1 (fr) * 1990-05-08 1991-11-09 Manzer Durrani Methode de sechage par pulverisation directe de solutions de lipides et de medicaments solubles dans l'eau
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
CA2295028A1 (fr) 1999-01-07
HUP0003207A3 (en) 2001-03-28
KR20010014163A (ko) 2001-02-26
IS5304A (is) 1999-12-15
HUP0003207A2 (hu) 2001-02-28
WO1999000111A1 (fr) 1999-01-07
AU7945698A (en) 1999-01-19
ID23192A (id) 2000-03-23
BR9810280A (pt) 2000-09-12
AU729100B2 (en) 2001-01-25
JP2002510311A (ja) 2002-04-02
SK184899A3 (en) 2000-05-16
TR199903271T2 (en) 2000-08-21
EP1001749A1 (fr) 2000-05-24
NO996439D0 (no) 1999-12-23
PL337723A1 (en) 2000-08-28
EE9900601A (et) 2000-08-15
NO996439L (no) 2000-02-28
NZ501672A (en) 2001-06-29
CN1260713A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
NZ298180A (en) Proliposome powders for inhalation
GB9626263D0 (en) Powder inhaler
AU5889398A (en) Powder inhaler
EP0768094A3 (fr) Dispositif d'inhalation de substance médicamenteuse sous forme pulvérulente
ZA9878B (en) New formulation for inhalation
PL335799A1 (en) Inhaler
PL335690A1 (en) Inhaler
PL335701A1 (en) Inhaler
AU135548S (en) Inhaler
AU135120S (en) Inhaler
HUP0002538A3 (en) Inhaler for powdered medicaments
HUP0100645A3 (en) Inhalation apparatus for powder medications
IL133478A0 (en) Proliposome powders for inhalation stabilised by tocopherol
AU135340S (en) An inhaler
GB9826783D0 (en) Inhalation powders
GB2324761B (en) Medico-surgical bags
AU134666S (en) Shoulder bag
ME01359B (fr) Appareil d'inhalation destine a des medicaments pulverulents
IL139218A0 (en) 2-aroyl-4-acyl-paclitaxel (taxol) analogs
GB2327623B (en) Powder production
AU3360497A (en) Aspartame powders for powder mixtures
GB2320900B (en) Inhalers
GB2329340B (en) Breathing aid
GB0211908D0 (en) Breathable gas mixtures
GB9325858D0 (en) De-odourising foot powder